World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
15986
World Ranking
11795
National Ranking
907

Anna Schuh publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Anna Schuh sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 308 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Anna Schuh D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Anna Schuh sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Anna Schuh is affiliated with the University of Oxford in the United Kingdom and has contributed extensively to research in the fields of medicine and biochemistry, genetics, and molecular biology. Their work spans various subfields including genetics, pathology and forensic medicine, cancer research, oncology, and molecular biology.

The scientist's research primarily focuses on topics related to chronic lymphocytic leukemia, lymphoma diagnosis and treatment, cancer genomics and diagnostics, viral-associated cancers and disorders, acute lymphoblastic leukemia, genetic factors in colorectal cancer, and acute myeloid leukemia.

Notable recent publications by Anna Schuh include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022, Leukemia
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms, 2022, Leukemia
  • Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease, 2023, New England Journal of Medicine
  • SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications, 2020, Leukemia
  • Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial, 2023, The Lancet Oncology

Frequent co-authors in Schuh's research include:

  • Toby A. Eyre
  • Piers Patten
  • Peter Hillmen
  • Christopher P. Fox
  • Andrew R. Pettitt

The scientist's work has been published in several prominent venues, reflecting a consistent focus on hematology and oncology research. Common publication venues include:

  • Blood
  • British Journal of Haematology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Leukemia
  • HemaSphere

The scope of Anna Schuh's research encompasses multiple aspects of cancer biology and hematologic diseases, contributing to the understanding and treatment strategies in these areas.

Best Publications

  • Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

    J. C. Byrd;J. R. Brown;Susan O'Brien;J. C. Barrientos

  • Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

    Jan A. Burger;Alessandra Tedeschi;Paul M. Barr;Tadeusz Robak

  • Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

    John C. Byrd;Bonnie Harrington;Susan O'Brien;Jeffrey A. Jones

  • Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

    Nicolas Goardon;Emanuele Marchi;Ann Atzberger;Lynn Quek

  • Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Jenny C. Taylor;Jenny C. Taylor;Hilary C. Martin;Stefano Lise;John Broxholme

  • Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

    Anna Schuh;Jennifer Becq;Sean Humphray;Adrian Alexa

  • Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.

    Stephan Stilgenbauer;Barbara Eichhorst;Johannes Schetelig;Peter Hillmen

  • SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage

    Ruth Clifford;Tania Louis;Pauline Robbe;Sam Ackroyd

  • Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.

    Peter Hillmen;Andy C. Rawstron;Kristian Brock;Samuel Muñoz-Vicente

  • Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

    Chulin Sha;Sharon Barrans;Francesco Cucco;Michael A. Bentley

  • Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

    Andrea Pellagatti;Richard N. Armstrong;Violetta Steeples;Eshita Sharma

  • Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

    Andrew R. Pettitt;Richard Jackson;Stacey Carruthers;James Dodd

  • Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia

    David Oscier;Claire Dearden;Efrem Eren;Christopher Fegan

  • The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.

    Katharina Schwarze;James Buchanan;James Buchanan;Jilles M Fermont;Helene Dreau

  • ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis

    Anna H. Schuh;Alex J. Tipping;Allison J. Clark;Isla Hamlett

  • Genetic variation at MECOM , TERT , JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

    William Tapper;Amy V. Jones;Robert Kralovics;Ashot S. Harutyunyan

  • Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

    Viktor Ljungström;Diego Cortese;Emma Young;Tatjana Pandzic

  • Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.

    C. Craddock;C. Craddock;L. Quek;N. Goardon;S. Freeman;S. Freeman

  • Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project

    Pauline Robbe;Niko Popitsch;Samantha J L Knight;Pavlos Antoniou

  • Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.

    Romain Guièze;Pauline Robbe;Ruth Clifford;Sophie de Guibert

Frequent Co-Authors

Peter Hillmen
Peter Hillmen St James's University Hospital
Jenny C. Taylor
Jenny C. Taylor University of Oxford
Samantha J.L. Knight
Samantha J.L. Knight University of Oxford
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Jennifer R. Brown
Jennifer R. Brown Harvard University
Paresh Vyas
Paresh Vyas University of Oxford
David Oscier
David Oscier Royal Bournemouth Hospital
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Tadeusz Robak
Tadeusz Robak Medical University of Lodz
Andy C. Rawstron
Andy C. Rawstron Leeds Teaching Hospitals NHS Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to diverse career paths, many of which now offer flexible, online degree options. If you're interested in healthcare data and administration, consider pursuing an online health information management degree. This pathway prepares you to manage patient records and work with medical systems, offering both job stability and opportunities for advancement.

Another in-demand option is medical coding. The medical coding salary is competitive, and the field requires strong biological and medical knowledge. If you want to know whether this is the right field for you, check out the medical coding job outlook for insights into job prospects, work environments, and growth potential.

For those passionate about health at the molecular level, a nutrition masters online can expand your expertise. This degree can lead to positions in clinical practice, research, or public health initiatives, all of which benefit from a background in biology or biochemistry.

Best Scientists Citing Anna Schuh

Trending Scientists

Recently Published Articles